Fujinaga K - Search Results

1

Direct and indirect effects of CYTOR lncRNA regulate HIV gene expression.

Kuzmina A, Sadhu L, Hasanuzzaman M, Fujinaga K, Schwartz JC, Fackler OT, Taube R. Kuzmina A, et al. Among authors: fujinaga k. PLoS Pathog. 2024 Apr 25;20(4):e1012172. doi: 10.1371/journal.ppat.1012172. eCollection 2024 Apr. PLoS Pathog. 2024. PMID: 38662769 Free PMC article.

2

Enhanced NF-κB activation via HIV-1 Tat-TRAF6 cross-talk.

Li Y, Liu X, Fujinaga K, Gross JD, Frankel AD. Li Y, et al. Among authors: fujinaga k. Sci Adv. 2024 Jan 19;10(3):eadi4162. doi: 10.1126/sciadv.adi4162. Epub 2024 Jan 19. Sci Adv. 2024. PMID: 38241362 Free PMC article.

3

[A Case of Unresectable Locally Advanced Descending Colon Cancer with an Extensive Retroperitoneal Abscess Treated by Curative Surgeries after Chemotherapy].

Haruki Y, Fujinaga K, Nakahashi H. Haruki Y, et al. Among authors: fujinaga k. Gan To Kagaku Ryoho. 2022 Dec;49(13):1980-1982. Gan To Kagaku Ryoho. 2022. PMID: 36733064 Japanese.

4

[A Case of Primary Omental Well-Differentiated Liposarcoma].

Fujinaga K, Nakahashi H, Haruki Y. Fujinaga K, et al. Gan To Kagaku Ryoho. 2022 Dec;49(13):1962-1964. Gan To Kagaku Ryoho. 2022. PMID: 36733058 Japanese.

5

P-TEFb: The master regulator of transcription elongation.

Fujinaga K, Huang F, Peterlin BM. Fujinaga K, et al. Mol Cell. 2023 Feb 2;83(3):393-403. doi: 10.1016/j.molcel.2022.12.006. Epub 2023 Jan 3. Mol Cell. 2023. PMID: 36599353 Free PMC article. Review.

6

Racial Disparities in Patient-Provider Communication During Telehealth Visits Versus Face-to-face Visits Among Asian and Native Hawaiian and Other Pacific Islander Patients With Cancer: Cross-sectional Analysis.

Acoba JD, Yin C, Meno M, Abe J, Pagano I, Tamashiro S, Fujinaga K, Braun-Inglis C, Fukui J. Acoba JD, et al. Among authors: fujinaga k. JMIR Cancer. 2022 Dec 9;8(4):e37272. doi: 10.2196/37272. JMIR Cancer. 2022. PMID: 36485021 Free PMC article.

7

Corrigendum to 'DCAF1 inhibits the NF-κB pathway by targeting p65'[Immunology Letters 249 (2022) 33-42].

Huang F, Yao W, Sun B, Fujinaga K. Huang F, et al. Among authors: fujinaga k. Immunol Lett. 2022 Dec;251-252:113. doi: 10.1016/j.imlet.2022.10.001. Epub 2022 Oct 21. Immunol Lett. 2022. PMID: 36280456 No abstract available.

8

DCAF1 inhibits the NF-κB pathway by targeting p65.

Huang F, Yao W, Sun B, Fujinaga K. Huang F, et al. Among authors: fujinaga k. Immunol Lett. 2022 Sep;249:33-42. doi: 10.1016/j.imlet.2022.08.005. Epub 2022 Aug 31. Immunol Lett. 2022. PMID: 36055411

9

P-TEFb is degraded by Siah1/2 in quiescent cells.

Huang F, Feng Y, Peterlin BM, Fujinaga K. Huang F, et al. Among authors: fujinaga k. Nucleic Acids Res. 2022 May 20;50(9):5000-5013. doi: 10.1093/nar/gkac291. Nucleic Acids Res. 2022. PMID: 35524561 Free PMC article.

10

New evaluation of the tumor immune microenvironment of non-small cell lung cancer and its association with prognosis.

Shinohara S, Takahashi Y, Komuro H, Matsui T, Sugita Y, Demachi-Okamura A, Muraoka D, Takahara H, Nakada T, Sakakura N, Masago K, Miyai M, Nishida R, Shomura S, Shigematsu Y, Hatooka S, Sasano H, Watanabe F, Adachi K, Fujinaga K, Kaneda S, Takao M, Ohtsuka T, Yamaguchi R, Kuroda H, Matsushita H. Shinohara S, et al. Among authors: fujinaga k. J Immunother Cancer. 2022 Apr;10(4):e003765. doi: 10.1136/jitc-2021-003765. J Immunother Cancer. 2022. PMID: 35396225 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

318 results

Search Page